-
The Safety of 3-phenyl-9H-carbazole
Time of Update: 2023-05-18
When handling PCZ, it is important to take appropriate safety measures to prevent exposure, and to seek medical attention immediately if you experience any symptoms of exposure.
-
The Safety of Starch
Time of Update: 2023-04-29
One of the key safety concerns surrounding starch is its potential to cause respiratory problems, particularly for those who work with it in a manufacturing setting.
One of the key safety concerns surrounding starch is its potential to cause respiratory problems, particularly for those who work with it in a manufacturing setting.
-
Express delivery of more than half of patients with ulcerative colitis that has been relieved for nearly 3 years, and Janssen IL-12/23 inhibitor has a positive long-term effect
Time of Update: 2021-08-09
Retrieved July 11, 2021, from https:/ / STELARA® (ustekinumab) Demonstrated Sustained Symptomatic and Corticosteroid-Free Remission Rates in Adults with Moderately to Severely Active Ulcerative Colitis at Nearly Three Years in Long-Term Extension of Phase 3 Trial.
-
Today, Howson Pharmaceuticals more than 200 million U.S. dollars co-development of CD19 antibody new drug market application was accepted by CDE
Time of Update: 2020-10-22
, the FDA approved inbilizumab for the treatment of patients with optic neurospinal cord disease who carry antibodies targeting the AQP4 water channel protein.
May 2019, Viela Bio announced a cooperation agreement with Howson Pharmaceuticals to jointly promote the development of in-inebilizumab for the treatment of NMOSD, autoimmune diseases and hemagnancy in China.
-
Read the diagnosis and treatment of epilepsy
Time of Update: 2020-09-30
The patient female, 13 years old, Dongguan, Guangdong, due to recurrent seizures of limb convulsions, accompanied by unclear consciousness for a year, aggravated by 1 day on January 4 hospitalization.
